Immunohistochemically, the tumor cells were positive for melanocytic (HMB-45 and Melan-A/MART-1) and myoid (desmin, smooth muscle actin, and muscle-specific actin/all muscle actin/HHF-35) markers (Figure 3). The gene discussed is MLANA; the disease is neoplasm.